Clinical Trials on 2,3,7,8-Tetrachlorodibenzo-Para-Dioxin (TCDD) Exposure
Total 1 results
-
National Cancer Institute (NCI)Completed2,3,7,8-Tetrachlorodibenzo-Para-Dioxin (TCDD) ExposureItaly
Sponsors and Collaborators
- Fondren Orthopedic Group L.L.P.
- Elim Pediatric Pharmaceuticals Inc.
- Cardresearch
- ProteoSys AG
- Celtaxsys Aus Pty Limited
- CRMBM-CEMEREM
- Alberta Children's Hospital, Calgary, Canada
- Victor Montori
- Societa Italiana di Endoscopia Digestiva
- Norsk Proteinintolerance, Norway
- The Fifth Affiliated Hospital of Zunyi Medical College
- University Medical Center Goettingen
- Caritas Freetown
- Diego Hernan Giunta, MD
- Ilustre Colegio Profesional de Fisioterapeutas de la Comunidad de Madrid
- AMTC & Associates
- San MediTech(Huzhou)Co.,Ltd.
- University Centre for Chronic Diseases Dekkerswald, Groesbeek, NL
- Donders Institute for Brain, Cognition and Behavior
- Rui-hua Xu, MD, PhD
- View Full List
Medical Conditions
- Atrial Fibrillation, Postoperative
- Non-compressible Torso Hemorrhage
- Auditory Hallucination, Verbal
- Gynecologic Cancer
- Plasmodium Falciparum Malaria (Drug Resistant)
- Non-dystrophic Myotonias
- Lymphedema of Arm
- Disturbance of Activity and Attention
- Tularaemia
- Postcomatose Unawareness State
- Fibromyalgia Syndrome, Primary
- Malignant Ascites Due to Epithelial Carcinoma
- Tube Disorders Eustachian
- Stereotactic Radioablation for Ventricular Tachycardia
- Spermatogenesis Arrest
- Analgesics, Antipyretics, and Antirheumatics Causing Adverse Effects in Therapeutic Use
- Fever, Sweats, and Hot Flashes
- Prostate Cancer Recurrent
- Orbital Tumor
- Normal Diameter of Optic Nerve
- View Full List
Drug Interventions
- Topotecan
- Indoximod
- Epimedium Prenylflavonoids Extract
- Insulin
- Bortezomib/dexamethasone
- HB-202 / HB-201 alternating intravenous administration + standard of care regimen including pembrolizumab.
- Mupirocin Calcium
- Lamivudine
- CTx-1301-Dexmethylphenidate 18.75mg (randomized fixed dose)
- Oxycodone, fentanyl
- Cytarabine ARA-C
- Polyethylene glycol 3350
- Flibanserin 100 mg dose every evening
- SERETIDE Diskus
- Atezolizumab
- PF-00868554
- Enzalutamide, Abiraterone
- Methotrexate
- Ruxolitinib
- Cetrorelix 78 mg + 78 mg
- View Full List
CROs by country
- Contract Research Organizations in Bahamas
- Contract Research Organizations in Germany
- Contract Research Organizations in Guinea
- Contract Research Organizations in Latvia
- Contract Research Organizations in Luxembourg
- Contract Research Organizations in Qatar
- Contract Research Organizations in Senegal
- Contract Research Organizations in Sweden
- Contract Research Organizations in Togo
- Contract Research Organizations in Trinidad & Tobago
- Contract Research Organizations in Turkmenistan
- Contract Research Organizations in Türkiye
- Contract Research Organizations in Uruguay
- CRO list by country